Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
reproductive toxicity, other
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
secondary literature

Data source

Reference
Reference Type:
secondary source
Title:
REPROTOX - PHENYL SALICYLATE
Author:
Truven Health Analytics Inc.
Year:
2013
Bibliographic source:
MICROMEDEX(R) Healthcare Series Vol. 157

Materials and methods

Results and discussion

Any other information on results incl. tables

Phenyl salicylate (Salol) is the phenyl ester of 2-hydroxybenzoic acid, used as an analgesic and in chemical manufacture. This agent was reported to be teratogenic in rats at an unspecified exposure level (1). We have been unable to locate references on possible human reproductive or lactation

effects of this compound.

Selected References

1. Nagahama M, Akiyama N, Miki T: Experimental production of malformations with salicylates (acetyl salicylate and phenyl salicylate) in rats. Congenital Anom 5:35, 1965; cited in Schardein JL, Chemically Induced Birth Defects, New York, Marcel Dekker, 3rd ed., 2000, p.148.

Applicant's summary and conclusion

Conclusions:
Phenyl salicylate was reported to be teratogenic in rats at an unspecified exposure level. We have been unable to locate references on possible human reproductive or lactation effects of this compound.